http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-960000893-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545
filingDate 1995-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1996-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-960000893-A
titleOfInvention Purification Method of Cephalosporin Salt
abstract The present invention provides 7- [2- (2-aminothiazol-4-yl) -2- (Z)-hydroxyiminoacetamido] -3-N, N-dimethylcarbamoyl of formula (I). P-toluenesulfonic acid salts of oxymethyl-3-cepem-4-carboxylic acid (isopropoxycarbonyloxy) ethylesters, their use in the preparation of other salts and pharmaceutical compositions containing them.
priorityDate 1994-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409908092

Total number of triples: 21.